Skip to content
Parker Institute for Cancer Immunotherapy
Search
Search Close

PICI BioTrust

All researchers have data from their studies. But data means little studied in isolation. Our BioTrust centralizes and standardizes patient samples, assay data and clinical outcomes from our network’s research projects and clinical trials to fuel next-level science. Our deeply comprehensive collection is shared throughout our network so that we’re not only igniting smarter research, but growing our own knowledge base at the same time – providing the foundation to advance discovery in patient diagnosis and treatment.

43K

Biospecimens

15

Transitional Suite Assays

Meet Our Experts

Our experienced professionals have extensive expertise in immuno-oncology patents and provide strategic guidance and advice throughout the process.

Cheryl Selinsky, PhD
Vice President, Research Operations

Christopher Perry
Associate Director, Biospecimen Acquisition and Operations

How We Stand Out

  • We give diligence its due. We apply rigorous quality control standards to ensure collected samples can be used immediately, not years later.
  • Data drives our decision making. Our deep sample analyses provide a more holistic view of a patient’s cancer and their immune system’s defensive response, enabling science that will help treat more patients and cancers.
  • Synergy is in our core. Our clinical trials and research studies are fully integrated within the BioTrust, which banks samples and reports testing results in a standardized way so comparisons across studies can further our understanding of immunotherapy’s promise and potential.
  • We power the research engine. Researchers can access our growing collection of 30,000+ tissue and blood samples to inform their research. In turn, they contribute data to our knowledge engine for others to access and build upon.